I combined with affinity chromatography, a 50-kDa protein which may mediate cellular transport of PMEA has been identified.
Phosphonomethoxyalkylpurines and pyrimidines are acyclic nucleotide analogs with potent and selective antiviral activities. One of the most effective compounds is 9-(2-phosphonomethoxyethyl)adenine (PMEA) (Fig. 1) , which is active against herpesviruses (13, 15) and retroviruses, including human immunodeficiency virus (5, 40, 51) . Moreover, its cytostatic effects (36, 37) and recently its immunomodulatory effects (28) have been reported. Other analogs of this compound and related series are also outstanding antiviral agents. (S)-9-(3-Hydroxy-2-phosphonomethoxypropyl)adenine (HPMPA) inhibits replication of many DNA viruses (1, 14, 30) , (S)-1-(3-hydroxy-2-phosphonomethoxypropyl)cytosine (HPMPC) is one of the most effective drugs against human cytomegalovirus (38, 49) , and 9-(2-phosphonomethoxyethyl)-2,6-diaminopurine (PMEDAP), (R)-9-(2-phosphonomethoxypropyl)adenine (PMPA), (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine (PMPDAP), and (S)-9-(3-fluoro-2-phosphonomethoxypropyl)-adenine (FPMPA) also possess strong antiretroviral activity (3, 4, 35) .
PMEA and other acyclic phosphonates are transformed by cellular enzymes to their diphosphoryl derivatives (2, 33) . These analogs of ribonucleoside 5Ј-and/or deoxyribonucleoside 5Ј-triphosphates are potent inhibitors of herpes simplex virus type 1 DNA polymerase (18) , human immunodeficiency virus and avian myeloblastosis virus reverse transcriptases (2, 53) , and herpes simplex virus type 1 ribonucleotide reductase (10) . Because phosphorylation of these drugs is not dependent on viral thymidine kinase, they are effective also against thymidine kinase-deficient virus strains (32) . In HeLa S3 cells, mere pretreatment with PMEA can effectively prevent herpes simplex virus type 1 replication (9) . In studies of PMEA metabolism in these cells using [2, H]PMEA, it has been found that besides PMEA and its phosphorylated derivatives (PMEAp and PMEApp), two more metabolites were present (9) . Experiments in the same cell line with the use of [adenine-U- 14 C]PMEA demonstrated the presence of PMEA, PMEAp, and PMEApp only. This discrepancy was explained later by extremely easy radiolysis of 2, H-labeled compound (8) . The question of the mechanism of transport of acyclic nucleoside phosphonates across the plasma membrane remains open. It is evident that, on account of the resistance of the P-C bond against dephosphorylating enzymes, their uptake via joint activities of ecto-5Ј-nucleotidase and nucleoside transporters, which is known for natural nucleotides (17, 48) , can be excluded. Recent studies also demonstrated the lack of dependence of PMEA and HPMPA cellular uptake on the S-(p-nitrobenzyl)-6-thioinosine-sensitive nucleoside transport system, and endocytosis was indicated as a possible common transport mechanism for these compounds in different cell types (39) . On the other hand, the inhibition of Na ϩ -dependent PMEA uptake by an excess of some natural nucleotides in Vero cells has been described (43) .
Detailed understanding of the transport mechanisms of these structurally unique, polar, small molecules could be of general biological significance. Therefore, we have studied in detail the transport of PMEA as a parent structure of acyclic nucleoside phosphonates. Our data demonstrate that PMEA is transported across the plasma membrane of HeLa cells via a concentrative process mediated by a membrane protein. Using inhibitory studies, we were able to obtain a more precise knowledge of the specificity of the transport process. Finally, we have identified the surface protein which may participate in the cellular uptake of this drug.
MATERIALS AND METHODS
Compounds. [U- 14 C]PMEA was further purified by ion-exchange chromatography as described previously (12) . Thereafter, radiochemical purity was found to be more than 99.7% when analyzed by reverse-phase high-performance liquid chromatography (HPLC) and ion pair HPLC. [2,8,5Ј- 3 H]ATP was obtained from New England Nuclear. Inulin-[
14 C]carboxylic acid and 3 H 2 O were purchased from Amersham. All acyclic nucleotide analogs and their derivatives were synthesized as described previously (22, 23, 34) . Nucleosides, nucleotides, and their derivatives were delivered by Sigma (St. Louis, Mo.) and Serva (Heidelberg, Germany). The purity of all compounds was analyzed by ion pair HPLC, and 1 mM sterile stock solutions were prepared. The concentrations were evaluated spectrophotometrically. Proteolytic enzymes (trypsin, V8 protease from Staphylococcus aureus, collagenase from Clostridium histolyticum, proteinase K, chymotrypsin, and papain), glycolytic enzymes (glycopeptidase F from Flavobacterium meningosepticum and neuraminidase from Salmonella typhimurium), concanavalin A, and lectin from Triticum vulgaris as well as all detergents were from Sigma.
Cells. HeLa S3 cells (ATCC CCL2.2) were maintained in a layer in RPMI 1640 medium supplemented with 5% fetal calf serum, 2 mM glutamine, 25 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid) (pH 7.4), 10 5 U of penicillin per liter, and 100 mg of streptomycin per liter. The cells were grown in a 5% CO 2 atmosphere at 37ЊC and passaged every 3 or 4 days, when the density reached 0.6 ϫ 10 6 to 0.7 ϫ 10 6 cells per ml. Suspension culture was cultivated under the same conditions but with magnetic stirring. Screening for Mycoplasma infection was carried out by fluorescent staining with Hoechst stain 33258 and by cultivation in the presence of 6-methylpurine 2Ј-deoxyriboside.
Measurement of PMEA uptake. Cells (10 6 per well) for the transport assay were seeded into a six-well dish. After 48 h, medium was removed and the cells were washed with transport medium (RPMI 1640 with 25 mM HEPES [pH 7.4] but without fetal calf serum and sodium bicarbonate). Thereafter, 1 ml of the same medium with [
14 C]PMEA (120 mCi/mmol) was added and the cells were incubated as indicated below. The uptake was stopped by chilling the cells on ice, and the radioactive medium was discarded. The layer was washed twice with 2 ml of ice-cold phosphate-buffered saline (PBS) and scraped into 1 ml of PBS (pH 7.5) supplemented with 0.5% bovine serum albumin (BSA). Cells were recovered by centrifugation at 4ЊC and solubilized by overnight incubation in 200 l of 0.2 M NaOH at 37ЊC. Cellular integrity after the washing step was controlled with trypan blue staining. Intracellular radioactivity was measured with an Aquasafe-500 scintillator (Zinsser Analytic, United Kingdom) on a Beckman LS-6000A counter. Cellular volume was evaluated by means of 3 H 2 O and [
14 C]carboxyinulin by a previously described method (57) .
All data are averages from at least two independent experiments with two parallel samples. The inhibitory constants were calculated by nonlinear regression.
Detection of PMEA intracellular metabolites. HeLa S3 cells were incubated with [ 14 C]PMEA for 180 min and washed as indicated above. The final cell pellet was extracted with 5% trichloroacetic acid. The extract was neutralized by being shaken with an equal volume of a Freon 113-trioctylamine mixture (4:1, vol/vol) and analyzed by ion pair HPLC on a Separon RPS SGX 7-m column (250 by 4.6 mm) (Tessek, Czech Republic). Elution buffer A contained 50 mM KH 2 PO 4 and 3 mM tetrabutylammonium hydrogen sulfate, pH 6.8. Buffer B had the same composition but also contained acetonitrile (20%, vol/vol). The separation was carried out with linear gradient from 85% buffer A-15% buffer B up to 30% buffer A-70% buffer B for 40 min with a flow rate of 1 ml/min. The radioactivity of 0.5-ml fractions was assayed following the addition of scintillation cocktail.
Enzyme treatment. Cells grown in suspension were washed in Dulbecco's PBS (DPBS) by low-speed centrifugation. Cells (5 ϫ 10 6 ) were suspended in 1 ml of DPBS containing proteolytic or glycolytic enzyme and treated at 37ЊC with mild shaking for 20 or 60 min. Thereafter, samples were diluted with 15 ml of RPMI plus 10% fetal calf serum to stop enzyme activities. Cell integrity was evaluated by trypan blue exclusion staining. Cells were recovered by centrifugation, resuspended in 1 ml of transport medium with 2 M [ 14 C]PMEA, and incubated for 15 min at 37ЊC with gentle shaking. After chilling on ice, the cells were centrifuged, the medium was aspirated, and the pellet was washed twice with 1 ml of PBS and then with 1 ml of PBS plus 0.5% BSA by centrifugation. Intracellular radioactivity was evaluated following the solubilization of the final cell pellet in 0.2 M NaOH.
Analysis of nucleotide decomposition. Cells plated into six-well dishes were incubated in transport medium with 1 M [
, and, as indicated below, 10 M PMEA was added. At various intervals, medium was removed and the layer was rinsed four times with 1 ml of ice-cold PBS. Medium combined with the rinsing PBS was analyzed by ion-exchange HPLC using a Whatman Partisil SAX column (100 by 3 mm). The elution was carried out with a linear concentration gradient of 0.01 to 0.8 M KH 2 PO 4 (pH 4.3) for 35 min with a flow rate of 0.5 ml/min. The radioactivity of 0.5-ml fractions was assayed, and cell-associated radioactivity was measured after solubilization of the culture in 1 ml of 0.2 M NaOH on a dish.
Preparation of affinity carriers. Three different ligands of two structural types were used for coupling to Sepharose 4B. (i) P 2 -(6-Aminohexyl) esters of PMEAp and PMEDAPp were synthesized by condensation of 6-benzyloxycarbaminohexyl phosphate and appropriate morpholides of PMEA or PMEDAP in dimethyl sulfoxide according to a general procedure followed by hydrogenolysis (35) . The compounds were isolated by chromatography on Dowex-1 in Cl Ϫ form.
(ii) N 6 -Aminohexyl-PMEDAP was prepared by nucleophilic displacement of a chlorine atom of 9-(diisopropylphosphonomethoxyethyl)-2-amino-6-chloropurine with 1,6-diaminohexane in anhydrous dioxane followed by transesterification of an ester group by bromotrimethylsilane treatment. The desired compound was purified on Dowex-1 in acetate form. The structures of all ligands were unequivocally proven by their 1 H and 31 P nuclear magnetic resonance spectra and UV spectra. Coupling of ligands to CNBr-activated Sepharose 4B (Pharmacia) was carried out according to the manufacturer's instructions with a 15 mM concentration of each ligand in coupling buffer. The remaining active groups were blocked with 0.2 M Tris ⅐ HCl, pH 8. The concentrations of coupled acyclic analogs (estimated spectrophotometrically) were 1.5 to 2 mol/ml of gel.
Membrane iodination and affinity chromatography. Membrane proteins of HeLa cells were selectively labeled with Na 125 I by a lactoperoxidase and glucoseglucose oxidase system (24) . Cells (5 ϫ 10 6 to 6 ϫ 10
6
) grown on 60-mmdiameter plastic dishes were washed three times with 5 ml of DPBS before being overlaid with 1 ml of DPBS containing 50 g of lactoperoxidase (Sigma), 100 mU of glucose oxidase (Sigma), and 5 mM glucose. Carrier-free Na 125 I (500 Ci per dish; Amersham) was added immediately, and the cell layer was incubated with gentle agitation for 20 min at room temperature. Labeled cells were rinsed five times with 5 ml of washing buffer (136 mM NaI, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 8 mM Na 2 HPO 4 ) and five times with 5 ml of PBS. The layer was scraped into 5 ml of ice-cold DPBS and centrifuged, and the pellet was solubilized in lysis buffer (31) (150 mM NaCl, 20 mM Tris ⅐ HCl [pH 7.5], 0.5% sodium dodecyl sulfate [SDS], 0.5% Nonidet P-40, 0.5 mM phenylmethanesulfonyl fluoride, 1 mM benzamidine, 100 g of aprotinin per ml, and 5 g each of leupeptin and pepstatin per ml). After 30 min at 0ЊC with occasional mixing, the sample was centrifuged at 50,000 ϫ g for 30 min, and the supernatant was incubated with affinity carrier for 90 min with end-over-end shaking at 4ЊC. Where indicated, the solubilizate was preincubated with excess PMEA before affinity chromatography. The carrier was extensively rinsed with lysis buffer, boiled in 4ϫ SDS gel loading buffer (containing dithiothreitol) (29) for 5 min, and pelleted. Supernatant was diluted and separated by electrophoresis on an SDS-10% polyacrylamide gel, which was fixed and dried. Autoradiography was carried out for 6 to 8 days with intensifying screens at Ϫ70ЊC. The time dependence of PMEA accumulation in HeLa cells indicates that during the incubation with 10 M PMEA the intracellular level of the compound increases in a linear manner for the first 10 min while a plateau is reached after roughly 1 h (Fig. 2) . To obtain more knowledge about this stage, we have replaced after 60 min the medium containing [ 14 C]PMEA by medium with the same concentration of unlabeled compound. The level of intracellular radioactivity decreased rapidly, and 60 min after the medium exchange it dropped to Ͻ50% (Fig. 2b) . This suggests that the plateau of intracellular concentration has a steady-state character, with PMEA influx and efflux in equilibrium. 
RESULTS
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The intracellular level of the drug depends also on its extracellular concentration, and it is saturated at approximately 1 M extracellular PMEA (Fig. 3) . With a double-reciprocal plot within the range of 0.1 to 0.5 M, the concentration of half-maximal saturation (K t ) and maximum rate of uptake (V max ) were 0. 6 cells. This value clearly indicates that, particularly on prolonged incubation, the actual intracellular concentration of PMEA reaches a level that is considerably higher than its concentration in medium. Moreover, we have demonstrated that phosphorylation of PMEA in HeLa cells is a relatively slow process: when cells are incubated in the presence of 1 M drug for 10 min, no phosphorylation is detected, and after 3 h PMEA itself still accounts for more than 90% of the total intracellular radioactivity (Fig. 4) . Thus, PMEA phosphorylation plays only a negligible role in the concentrative intracellular accumulation. These data obviously indicate that PMEA transport can proceed against concentration gradients.
PMEA uptake is also considerably temperature dependent. While at 21ЊC the total influx amounts to only 20% of that at 37ЊC, at 4ЊC the uptake is inhibited completely (Fig. 3) .
The concentrative character and the saturability of the transport process suggest that it is probably mediated by a plasma membrane transporter or receptor. A similar conclusion follows from the investigation of the dependence of PMEA uptake on cellular density. The observed maximum (Fig. 5) be accounted for by two mutually opposing effects: stimulation at low cell density and inhibition at high densities. In this connection, it ought to be noted that a high cell density negatively interferes with the expression or function of many membrane proteins (25, 44, 45) . Susceptibility of PMEA uptake to enzyme treatment. To further confirm the existence of the membrane transport protein, we have investigated the effects of proteolytic and glycolytic enzymes on PMEA cellular uptake. For this purpose, we have used a modified transport assay for suspension culture (see Materials and Methods). Figure 6 indicates a significant reduction of PMEA permeation following treatment of cells with sequentially specific (trypsin, V8 protease, and collagenase) as well as nonspecific (chymotrypsin, papain, and proteinase K) proteases. It is not surprising that the effect of nonspecific proteases is more substantial; on the contrary, collagenase, an enzyme with a highly specific target sequence, does not have any effect even after prolonged treatment. Because most of the cellular surface proteins are glycosylated, we evaluated also the effect of glycolytic enzymes upon PMEA uptake. Treatment with neuraminidase causes only a small decrease of transport activity, while glycopeptidase F has no effect even at higher enzyme concentrations. However, this fact might also be explained by poor glycolytic digestion of native glycoproteins (11) . It is supported by the finding that lectins inhibit PMEA uptake. After 20-min preincubation of the cells with 50 g of concanavalin A or lectin from T. vulgaris per ml, the transport is decreased by 32 and 40%, respectively (data not shown).
Structure specificity of transport process. To characterize further the transport process, we have investigated the inhibitory effect of structurally related acyclic nucleoside phosphonates on PMEA cellular uptake. The experiments were carried out under saturation conditions (5 M concentration of [ 14 C]PMEA). Table 1 shows that purine PME derivatives are effective inhibitors, and, as expected, the inhibition has a competitive character, with a K i for PMEDAP of 0.24 M and a K i for 9-(2-phosphonomethoxyethyl)guanine (PMEG) of 0.68 M (Fig. 7) . Pyrimidine derivatives are less inhibitory; 9-(2-phosphonomethoxyethyl)thymine (PMET) is without any effect even when added in great excess. Moreover, substitution of an adenine ring at position 8 seems to completely prevent the interaction with the transport system. Also, the decrease or increase in number of nitrogen atoms in the heterocyclic moiety seems to markedly decrease the inhibitory effect of such compounds on PMEA uptake.
A free phosphonate group is indispensable for PMEA interaction with the transport system, since its esterification (PMEA mono-and diethyl esters) as well as its phosphorylation (PMEAp and PMEApp) prevents or strongly decreases the ability to interact with PMEA uptake. Importantly, the substitution of an acyclic chain in the 2Ј position is also crucial, since both enantiomers of HPMPA are only weak inhibitors while both forms of PMPA, FPMPA, and other related 2Ј-substituted structures are without any effect (Table 1) .
Inhibitory effect of nucleosides and nucleotides. Several nucleoside transport systems in a number of cell types have been described in detail so far (41) . For the Hela S3 cell membrane, only a low-affinity, high-capacity transporter has been identified (56) . However, this transport system does not mediate PMEA penetration, since the addition of adenosine, thymidine, and uridine to a 20-fold excess has no effect on PMEA uptake. Similarly, PMEA under saturation conditions does not affect cellular entry of [ (5), and papain (6) were used at concentrations of 100 (open bars) and 500 (solid bars) g/ml. N-Glycopeptidase (7) and neuraminidase (8) treatments were carried out with 5 and 0.5 U/ml, respectively. After a washing, the cells were incubated with 2 M [ 14 C]P-MEA for 15 min at 37ЊC and PMEA uptake was evaluated. As a control, PMEA uptake (100%) was measured under the same conditions but enzymes in DPBS were omitted. groups, their effect decreases in the order of nucleoside 3Ј-monophosphates (3Ј-NMPs), 5Ј-NMPs, nucleoside 5Ј-diphosphates, 2Ј-NMPs, and nucleoside 5Ј-triphosphates (Fig. 8) . The inhibition is also considerably influenced by the type of nucleobase; the pattern T ϭ A Ͼ G Ͼ C Ͼ U is generally valid for all the nucleotide types mentioned above. Surprisingly, in contrast to 8-bromo-PMEA, 8-bromo-AMP is one of the most potent inhibitors identified ( Table 2 ). The same discrepancy was also found for thymine derivatives (dTMP versus PMET). With regard to the character of inhibition, we were interested primarily in ATP, whose ability to influence the permeability of the plasma membrane via P 2 -purinergic receptors has been reported many times (7, 50) . However, Fig. 7c and d clearly indicate a competitive character of inhibition with 5Ј-AMP and ATP. Similar results were also obtained with 3Ј-AMP and 5Ј-dTMP. The unusual (nonlinear) course may be explained by partial dephosphorylation of nucleotides to inactive nucleosides which takes place simultaneously, since most cell types, including HeLa cells, express active 5Ј-nucleotidase, alkaline phosphatase, and nucleoside triphosphatase on their surface (6, 52) . To verify this assumption, we have incubated HeLa cells in the presence of 1 M [ 14 C]AMP with or without addition of 10 M PMEA. We have observed relatively fast decomposition of AMP to adenosine, which immediately enters the cells via a nucleoside transporter. A change in extracellular AMP/adenosine ratio was detected in the presence of PMEA, but the effect was not very significant when the large excess over AMP was taken into account. The level of intracellular radioactivity was not influenced by PMEA (Fig. 9 ). Also, [ 3 H]ATP was dephosphorylated during incubation with HeLa cells (data not shown). To determine whether the inhibitory activity of nucleoside triphosphates is due solely to the influence of their dephosphorylation products, we have evaluated the effects of ␤,␥-imino-ATP and ␤,␥-methylene-ATP, two dephosphorylation-resistant ATP analogs. Both compounds inhibit the transport of PMEA approximately as efficiently as ATP (Table 2) .
Recently, a protein that binds P 1 ,P 4 -di(adenosine-5Ј)tetraphosphate (Ap 4 A) has been identified in the plasma mem- brane of mammalian cells (21) . Therefore, we have studied the effect of Ap 4 A on PMEA uptake. This compound, similarly to adenine-containing coenzymes (NAD and flavin adenine dinucleotide), is a rather weak inhibitor in comparison with mononucleotides ( Table 2) . Of other adenosine derivatives bearing a polar group, S-adenosyl-L-methionine and S-adenosyl-L-homocysteine do not possess any inhibitory activity. The phosphorylated sugars (ribose 1-phosphate and ribose 5-phosphate) do not exhibit any effect upon PMEA uptake, either. PMEA-binding protein in plasma membrane of HeLa cells. To identify the membrane protein participating in PMEA transport, we have used specific labeling of cell surface proteins with Na 125 I combined with affinity chromatography. Lysate of iodinated HeLa cells was incubated with N 6 -aminohexyl-PMEDAP-Sepharose 4B, and surface proteins bound on the affinity carrier were detected by autoradiography following SDS-polyacrylamide gel electrophoresis. In this way, we have identified a 50-kDa protein which binds specifically to derivatized Sepharose. When the cell lysate was preincubated with excess PMEA prior to the application to affinity carrier or when the lysate was applied to Sepharose 4B bearing no ligand, this protein was not detected (Fig. 10) .
Analogous experiments were carried out also with additional affinity ligands mentioned in Materials and Methods. However, their ability to bind any labeled membrane protein was very poor. We have also investigated different biological detergents for solubilization of iodinated cells. Besides an SDS-Nonidet P-40 mixture, we have used Na ϩ -cholate, n-octyl-glucoside, Triton X-100, and digitonine at 0.5 to 1.5% concentrations. Nevertheless, in the presence of these detergents, the affinity binding was very weak or nonspecific and in some cases no protein was detected at all (data not shown).
DISCUSSION
Very few data on the mechanism and selectivity of the cellular transport of acyclic nucleoside phosphonates have been reported so far. The aim of this study was to investigate the fundamental characteristics and specificity of PMEA uptake. Our data show that the intracellular level of PMEA in HeLa S3 cells reaches a plateau after 1 h of incubation with the drug. This state is characterized by the equilibrium of the influx and efflux of the drugs. The transport process is saturable, and in comparison with Vero cells (43) , a greater affinity for PMEA was demonstrated in HeLa cells (the K t value is nearly 2 orders of magnitude lower). The transport process has a concentrative character, since at low extracellular concentrations the intracellular level is up to 10-fold higher. This phenomenon indicates the existence of a membrane transport protein. This assumption is supported by the sensitivity of the transport to protease treatment as well as by the considerable decrease of PMEA uptake at high cell densities. A similar dependence on cell density has been found for P i (54) , nucleoside (55) , and phosphorothioate oligonucleotide (25) transport systems, which are always mediated by membrane receptors or transporters. A negative effect of high cell density on the expression of surface receptors for different growth factors was also described previously (44, 45) .
The transport process is strictly structure specific. PMEA uptake is not affected by closely related side chain-substituted compounds (HPMPA, PMPA, and FPMPA). It would be valuable to ascertain whether these nucleoside phosphonates enter cells via different transport system(s) or whether they are not able to penetrate HeLa cells at all.
Neither nucleosides nor nucleobases inhibit transport of PMEA. This finding is in agreement with data obtained for other cell types (39) . On the other hand, some of the natural ribonucleotides are strong competitive inhibitors. The pronounced discrepancy between the inhibitory effects of thymine and 8-bromoadenine nucleotides and the corresponding PME derivatives upon PMEA transport probably reflects the difference in their interaction with the transport system with respect to the rather flexible acyclic molecule compared with the more rigid nucleotide conformation.
The inhibitory constants for nucleotides could not be precisely determined because of the effect of ectoenzymes (6, 52) which dephosphorylate nucleotides to nucleosides which subsequently enter cells via membrane transporters (41) . We have observed that this conjugated-nucleotide uptake is relatively rapid in the case of AMP and that PMEA does not substantially affect this process. In this regard, it should be noted that the different inhibitory effects of 2Ј-, 3Ј-, and 5Ј-NMPs on PMEA uptake could reflect the consequence of different dephosphorylation rates.
During our investigation, we have identified a 50-kDa plasma membrane protein in HeLa cells which is able to bind specifically PMEDAP and PMEA and thus may participate in PMEA transport. Several other surface proteins with potential ability to interact with these nucleotide analogs should also be taken into account. However, the 5Ј-nucleotidase mentioned above is a 70-kDa conservative protein in mammalian cells (19) , and alkaline phosphatase, which has been identified directly in HeLa cells, is a 67-kDa protein (26) . These arguments support our assumption that the 50-kDa protein which we have identified may play a role in cellular uptake of PMEA.
Two transport systems whose activity is inhibited by natural nucleotides in mammalian cells have been described so far. One of them is an 80-kDa receptor for oligonucleotide endocytosis identified in human HL60 cells. However, this protein does not interact with 2Ј-and 3Ј-NMPs (31). Another transport system has been described for reduced folate-methotrexate uptake. In murine L1210 cells, the methotrexate uptake is inhibited by adenine nucleotides in the order of ATP Ͼ ADP Ͼ AMP (20) , which is the opposite of our observation for the PMEA transport system. However, this study did not take into account possible dephosphorylation. The methotrexate carrier in L1210 cells is a 46-to 48-kDa membrane protein (42) . This molecular mass is close to that of the protein we have identified. Moreover, in the membrane of human KB cells, a 50-kDa folate-binding protein with the ability to transport methotrexate was demonstrated (16, 47) . The reduced folate-methotrexate transport system has also been described for HeLa cells (46) . It could not be excluded that the methotrexate carrier could participate in PMEA cellular transport. However, we found that neither methotrexate nor 5-methyltetrahydrofolate inhibits PMEA uptake even if added in very high excess over their K t values evaluated in HeLa cells (data not shown). Consequently, we suppose that the transport system characterized in this paper is newly identified and so far undescribed in the literature.
Our data point indirectly to endocytosis as the general transport mechanism for PMEA uptake. It is supported by the following facts: (i) transport of PMEA is considerably temperature sensitive and enables concentrative intracellular accumulation of the drug, and (ii) in a defined range, transport of PMEA is stimulated by increasing cellular density. It has been shown that endocytosis is enhanced in HeLa cells with increasing density (27) . These findings are consistent with the data reported earlier for other cell lines which also suggest endocytosis as a possible transport mechanism for PMEA uptake (39) .
The results presented in this study indicate that the described transport system with its strict structural specificity could be one of the factors controlling the biological activity of PMEA and several related acyclic nucleoside phosphonates in HeLa cells. It will be important to find out whether the transport characteristics described above are of broader validity.
